FIELD: medicine, allergology, pharmacology, pharmacy.
SUBSTANCE: invention proposes a new gent eliciting an anti-allergic effect. Agent represents glucuronic acid that is known early as a stimulating agent of granulomonocytopoeisis. Agent effects on the more early stages in formation of allergic responses associated with producing immunoglobulins.
EFFECT: valuable medicinal properties of agent, expanded assortment of agents of claimed designation.
4 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT OF ANTIALLERGIC ACTION | 2007 |
|
RU2337699C1 |
AGENT BASED ON WATER-SOLUBLE VEGETABLE POLYSACCHARIDES, HAVING ANTIALLERGIC ACTIVITY | 2023 |
|
RU2823873C1 |
ANTIALLERGIC AGENT | 2008 |
|
RU2378004C1 |
PRODUCT OF HUMIC NATURE WITH ANTI-ALLERGIC ACTIVITY | 2020 |
|
RU2750098C1 |
ANTIALLERGIC PREPARATION | 2008 |
|
RU2379047C1 |
DRUG OF HUMIC NATURE, WHICH HAS AN IMMUNOMODULATORY EFFECT | 2022 |
|
RU2783772C1 |
ALLERGOIDS PREPARED OF ALLERGENS | 2009 |
|
RU2522490C2 |
ANTIIDIOTYPICAL ANTIBODY FOR ANTIBODIES INHIBITING IMMUNOGLOBULIN BONDING TO ITS HIGH AFFINITY RECEPTOR | 2000 |
|
RU2253655C2 |
AGENT WITH IMMUNOPOTENTIATING ACTIVITY | 2007 |
|
RU2347562C2 |
VACCINE SHOWING CAPABILITY TO CAUSE IMMUNE RESPONSE AGAINST THE SELF-IGE BODY, METHOD OF VACCINE PREPARING AND METHOD OF MAMMAL IMMUNIZATION AGAINST IGE-MEDIATED ALLERGIC RESPONSES | 1992 |
|
RU2120805C1 |
Authors
Dates
2004-11-27—Published
2003-10-02—Filed